Lakewood-Amedex Biotherapeutics, Inc. Stock Analysis & AI Score
Lakewood-Amedex Biotherapeutics, Inc. (LABT) has an ST Score of 41.1 (C), driven by its Financial Strength (B) and held back by its Momentum (D+). LABT last traded at $1.82.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lakewood-Amedex Biotherapeutics, Inc. (LABT) has an ST Score of 41.1 (C), driven by its Financial Strength (B) and held back by its Momentum (D+). LABT last traded at $1.82.
- Strongest
- Financial StrengthB
- Weakest
- MomentumD+
All factor grades
- Financial StrengthB
- GrowthC+
- ValuationC
- ProfitabilityC-
- MomentumD+
Contact
LABT stock: frequently asked questions
What is LABT's ST Score?
Lakewood-Amedex Biotherapeutics, Inc. (LABT) has an ST Score of 41.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LABT a buy, hold, or sell?
Our ST Score grades it C (41.1/100). The ST Score is a data-driven signal, not a recommendation.
What are LABT's factor grades?
Valuation C, Profitability C-, Financial Strength B, Momentum D+, Growth C+.
What is LABT's valuation grade?
Lakewood-Amedex Biotherapeutics, Inc. (LABT) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LABT's growth grade?
Lakewood-Amedex Biotherapeutics, Inc. (LABT) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LABT's profitability grade?
Lakewood-Amedex Biotherapeutics, Inc. (LABT) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LABT's financial strength grade?
Lakewood-Amedex Biotherapeutics, Inc. (LABT) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.